We are live on ! Find out more
BM

Brandywine Managers Portfolio holdings

AUM $202M
1-Year Est. Return 16.99%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$94.9M
AUM Growth
+$1.87M
Cap. Flow
+$173K
Cap. Flow %
0.18%
Top 10 Hldgs %
83.48%
Holding
37
New
2
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
KVYO icon
Klaviyo
KVYO
+$332K
2
TWLO icon
Twilio
TWLO
+$215K
3
PATH icon
UiPath
PATH
+$125K

Top Sells

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$500K

Sector Composition

Rank Sector Weight
1 Technology 44.59%
2 Miscellaneous 42.8%
3 Healthcare 11.35%
4 Financials 0.99%
5 Consumer Discretionary 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
26
Moderna
MRNA
$58.1B
$395K 0.42%
9,510
– –
NVO
27
Novo Nordisk
NVO
$206B
$363K 0.38%
4,222
– –
KVYO icon
28
Klaviyo
KVYO
$5.3B
$358K 0.38%
+8,692
New +$332K
VKTX icon
29
Viking Therapeutics
VKTX
$4.07B
$325K 0.34%
8,082
– –
GH icon
30
Guardant Health
GH
$21.7B
$313K 0.33%
10,233
– –
GPCR icon
31
Structure Therapeutics
GPCR
$3.38B
$300K 0.32%
11,057
– –
BEAM icon
32
Beam Therapeutics
BEAM
$3.06B
$280K 0.3%
11,306
– –
MBLY icon
33
Mobileye
MBLY
$7.28B
$260K 0.27%
13,067
– –
TWLO icon
34
Twilio
TWLO
$35.8B
$255K 0.27%
+2,357
New +$215K
RLAY icon
35
Relay Therapeutics
RLAY
$4.17B
$158K 0.17%
38,429
– –
TXG icon
36
10x Genomics
TXG
$8.16B
$145K 0.15%
10,073
– –
ABCL icon
37
AbCellera Biologics
ABCL
$3.7B
$83.5K 0.09%
28,488
– –
1
2

Similar funds

OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
WPW
Winthrop Partners - WNY Buffalo, New York $202M AUM
HWA
Hilltop Wealth Advisors Chapel Hill, North Carolina $202M AUM 24.55% 1-Year Est. Return
DFG
Delphi Financial Group Wilmington, Delaware $202M AUM 21.25% 1-Year Est. Return
LAMC
Longview Asset Management (California) San Rafael, California $202M AUM 11.36% 1-Year Est. Return
FC
Farringdon Capital London, United Kingdom $202M AUM 4.1% 1-Year Est. Return
ER
EVR Research Richmond, Virginia $203M AUM 60.82% 1-Year Est. Return
MRCM
Mill Road Capital Management Greenwich, Connecticut $203M AUM 79.43% 1-Year Est. Return

Brandywine Managers's Q4 2024 Portfolio in Review

As of Q4 2024, Brandywine Managers held 37 positions worth $94.9M, up 2% from $93M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Brandywine Managers's Q4 2024 filing shows 2 new, 1 increased and 1 reduced positions. Its largest new stake was Klaviyo: 8,692 shares worth $358K. The largest sale was iShares MSCI ACWI ETF, an estimated $500K.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 42% a quarter earlier, followed by Miscellaneous and Healthcare.

  • Brandywine Managers's largest Q4 2024 buy was Klaviyo: 8,692 shares worth $358K.
  • Brandywine Managers added most to UiPath in Q4 2024, an estimated $125K increase.
  • Brandywine Managers's biggest Q4 2024 reduction was iShares MSCI ACWI ETF, cutting an estimated $500K.
  • Brandywine Managers's ten largest holdings make up 83% of its $94.9M portfolio in Q4 2024.
  • Brandywine Managers opened 2 new positions and closed 0 in Q4 2024.
  • Brandywine Managers's portfolio value rose 2% quarter-over-quarter to $94.9M.

Based on Brandywine Managers's 13F filing for Q4 2024, filed 13 Feb 2025.